Related Experiment Videos
[Clinical studies on cefprozil in pediatrics]
T Sekiguchi1, Y Shiino, K Murakawa
1Department of Pediatrics, Takamatsu Red Cross Hospital.
Insights
Cefprozil (CFPZ) demonstrated effectiveness in treating pediatric bacterial infections, achieving excellent clinical responses in most children. This antibiotic proved useful for conditions like acute tonsillitis, bronchitis, and urinary tract infections.
Area of Science:
- Pediatric Infectious Diseases
- Clinical Pharmacology
- Bacteriology
Background:
- Acute bacterial infections pose a significant health challenge in children.
- Effective and safe antibiotic options are crucial for pediatric care.
- Cefprozil is a third-generation cephalosporin with broad-spectrum activity.
Purpose of the Study:
- To evaluate the clinical efficacy and safety of Cefprozil (CFPZ) fine granules in pediatric patients.
- To assess the bacterial eradication rates of CFPZ in various acute infections.
Main Methods:
- Oral administration of Cefprozil fine granules to 21 children with acute bacterial infections.
- Infections included acute tonsillitis, acute bronchitis, and urinary tract infections.
- Clinical response and bacterial eradication were monitored.
Main Results:
- Good to excellent clinical responses were observed in 19 out of 21 pediatric patients.
- Complete bacterial eradication was achieved for all 11 identified bacterial strains.
- Adverse events were minimal, with one case each of loose stool and eosinophilia.
Conclusions:
- Cefprozil (CFPZ) is a potentially useful antibiotic for treating pediatric bacterial infections.
- The drug exhibited a favorable clinical response and safety profile in the evaluated pediatric population.
- CFPZ demonstrated high efficacy in eradicating common bacterial pathogens in children.
Abstract:
Cefprozil (CFPZ, BMY-28100) fine granules were given orally to 21 children with acute bacterial infections including 15 cases of acute tonsillitis and 3 each of acute bronchitis and urinary tract infections. Good to excellent clinical responses were obtained in 19 of the 21 patients and bacterial eradications were obtained for all 11 strains found in these cases. Loose stool and eosinophilia were observed in 1 case each. From the above clinical results, it appears that CFPZ is a useful antibiotic for the treatment of pediatric patients with various bacterial infections.